287 related articles for article (PubMed ID: 16527460)
1. Interaction of local anaesthetics with other antifungal agents against pathogenic Aspergillus.
Rodrigues AG; Araujo R; Pina-Vaz C
Int J Antimicrob Agents; 2006 Apr; 27(4):339-43. PubMed ID: 16527460
[TBL] [Abstract][Full Text] [Related]
2. Synergism of CAY-1 with amphotericin B and itraconazole.
De Lucca AJ; Bland JM; Boue S; Vigo CB; Cleveland TE; Walsh TJ
Chemotherapy; 2006; 52(6):285-7. PubMed ID: 17008779
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic model.
Meletiadis J; Al-Saigh R; Velegraki A; Walsh TJ; Roilides E; Zerva L
Antimicrob Agents Chemother; 2012 Jan; 56(1):403-10. PubMed ID: 22064546
[TBL] [Abstract][Full Text] [Related]
4. Post-antifungal effect of amphotericin B and voriconazole against germinated Aspergillus fumigatus conidia.
Chryssanthou E; Loebig A; Sjölin J
J Antimicrob Chemother; 2008 Jun; 61(6):1309-11. PubMed ID: 18367461
[TBL] [Abstract][Full Text] [Related]
5. Effect of methotrexate on the germination and growth of Aspergillus fumigatus and Aspergillus flavus strains.
Warnock DW; Oliver DA; Cheung MM; Zurick NJ
J Antimicrob Chemother; 1992 Apr; 29(4):375-81. PubMed ID: 1607326
[TBL] [Abstract][Full Text] [Related]
6. Human albumin promotes germination, hyphal growth and antifungal resistance by Aspergillus fumigatus.
Rodrigues AG; Araujo R; Pina-Vaz C
Med Mycol; 2005 Dec; 43(8):711-7. PubMed ID: 16422301
[TBL] [Abstract][Full Text] [Related]
7. Givinostat exhibits in vitro synergy with posaconazole against Aspergillus spp.
Sun Y; Gao L; He C; Wu Q; Li M; Zeng T
Med Mycol; 2017 Oct; 55(7):798-802. PubMed ID: 27915302
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of fungicidal activities of voriconazole and amphotericin B against hyphae of Aspergillus fumigatus.
Krishnan S; Manavathu EK; Chandrasekar PH
J Antimicrob Chemother; 2005 Jun; 55(6):914-20. PubMed ID: 15824093
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy of amphotericin B, clotrimazole and itraconazole against Aspergillus spp. An in vitro study.
Hahn YH; Ahearn DG; Wilson LA
Mycopathologia; 1993 Sep; 123(3):135-40. PubMed ID: 8302362
[TBL] [Abstract][Full Text] [Related]
10. [Medium optimization for antagonistic Streptomyces S24 and its inhibition on Aspergillus flavus].
Zhou Q; Liu X; Zhang N; Song Z; Qiu N; Zhang B; Guo H; Lü C; Yu J
Sheng Wu Gong Cheng Xue Bao; 2011 Feb; 27(2):203-11. PubMed ID: 21650044
[TBL] [Abstract][Full Text] [Related]
11. Effect of increasing inoculum sizes of Aspergillus hyphae on MICs and MFCs of antifungal agents by broth microdilution method.
Lass-Flörl C; Speth C; Kofler G; Dierch MP; Gunsilius E; Würzner R
Int J Antimicrob Agents; 2003 Mar; 21(3):229-33. PubMed ID: 12636983
[TBL] [Abstract][Full Text] [Related]
12. Indolinone derivatives as potential antimicrobial agents.
Singh SP; Jha K
Zentralbl Mikrobiol; 1989; 144(2):105-9. PubMed ID: 2501946
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterisation of cyp51A and cyp51B genes coding for P450 14alpha-lanosterol demethylases A (CYP51Ap) and B (CYP51Bp) from voriconazole-resistant laboratory isolates of Aspergillus flavus.
Krishnan-Natesan S; Chandrasekar PH; Alangaden GJ; Manavathu EK
Int J Antimicrob Agents; 2008 Dec; 32(6):519-24. PubMed ID: 18775650
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antimicrobial activity of 3-arylamino-1-chloropropan-2-ols.
Prasad AK; Kumar P; Dhawan A; Chhillar AK; Sharma D; Yadav V; Kumar M; Jha HN; Olsen CE; Sharma GL; Parmar VS
Bioorg Med Chem Lett; 2008 Mar; 18(6):2156-61. PubMed ID: 18281215
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of conidiophore development in Aspergillus fumigatus by an Escherichia coli DH5α strain, a promising antifungal candidate against aspergillosis.
Balhara M; Ruhil S; Kumar M; Dhankhar S; Chhillar AK
J Mycol Med; 2014 Mar; 24(1):1-12. PubMed ID: 23978655
[TBL] [Abstract][Full Text] [Related]
16. The action of itraconazole and ketoconazole on growth and sterol synthesis in Aspergillus fumigatus and Aspergillus niger.
Marichal P; Gorrens J; Vanden Bossche H
Sabouraudia; 1985 Feb; 23(1):13-21. PubMed ID: 2986303
[TBL] [Abstract][Full Text] [Related]
17. MIC and fungicidal activity of terbinafine against clinical isolates of Aspergillus spp.
Schmitt HJ; Bernard EM; Andrade J; Edwards F; Schmitt B; Armstrong D
Antimicrob Agents Chemother; 1988 May; 32(5):780-1. PubMed ID: 3134851
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
Kaya AD; Kiraz N
Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704
[TBL] [Abstract][Full Text] [Related]
19. Rapid method for testing the susceptibility of Aspergillus fumigatus to amphotericin B, itraconazole, voriconazole and posaconazole by assessment of oxygen consumption.
Araujo R; Coutinho I; Espinel-Ingroff A
J Antimicrob Chemother; 2008 Dec; 62(6):1277-80. PubMed ID: 18824456
[TBL] [Abstract][Full Text] [Related]
20. In vitro evaluation of aureofungin against two fruit rot fungi.
Laxminarayana P; Reddy SM
Hindustan Antibiot Bull; 1974; 17(1-2):29-30. PubMed ID: 4466821
[No Abstract] [Full Text] [Related]
[Next] [New Search]
